{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:24:46Z","timestamp":1790630686638,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1006\/exnr.1999.7289","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T11:46:56Z","timestamp":1032176816000},"page":"647-663","source":"Crossref","is-referenced-by-count":208,"title":["Loss of Cholinergic Phenotype in Basal Forebrain Coincides with Cognitive Decline in a Mouse Model of Down's Syndrome"],"prefix":"10.1006","volume":"161","author":[{"given":"Ann-Charlotte E.","family":"Granholm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda S.","family":"Crnic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/exnr.1999.7289_RF1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/geno.1998.5335","article-title":"10 years of genomics, chromosome 21, and Down syndrome","volume":"51","author":"Antonarakis","year":"1998","journal-title":"Genomics"},{"key":"10.1006\/exnr.1999.7289_RF2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000106594","article-title":"Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease","volume":"8","author":"Boissiere","year":"1997","journal-title":"Dementia Geriatric Cog. Disord."},{"key":"10.1006\/exnr.1999.7289_RF3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1006\/exnr.1997.6443","article-title":"Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease","volume":"145","author":"Boissiere","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.1999.7289_RF4","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1523\/JNEUROSCI.16-17-05437.1996","article-title":"Systemic administration of a nerve growth factor conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy","volume":"16","author":"B\u00e4ckman","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.1999.7289_RF5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ana.410180306","article-title":"Abnormalities of the nucleus basalis in Down's syndrome","volume":"18","author":"Casanova","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1999.7289_RF6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0006-8993(96)00398-8","article-title":"Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate","volume":"728","author":"Charles","year":"1996","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1999.7289_RF7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0306-4522(94)90462-6","article-title":"Reduced transport of (125I) nerve growth factor by cholinergic neurons and down-regulated TrkA expression in the medial septum of aged rats","volume":"62:","author":"Cooper","year":"1994","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1999.7289_RF8","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1073\/pnas.88.5.1793","article-title":"Nerve growth factor corrects developmental impairments of basal forebrain cholinergic neurons in the trisomy 16 mouse","volume":"88:","author":"Corsi","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.1999.7289_RF9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0022-3956(84)90037-2","article-title":"Neurotransmitter specific alterations in dementing disorders: Insights from animal models","volume":"18:","author":"Coyle","year":"1984","journal-title":"J. Psych. Res."},{"key":"10.1006\/exnr.1999.7289_RF10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0361-9230(86)90074-2","article-title":"The neurobiologic consequences of Down's syndrome","volume":"16:","author":"Coyle","year":"1986","journal-title":"Brain Res. Bull."},{"key":"10.1006\/exnr.1999.7289_RF11","first-page":"390","article-title":"Down syndrome, Alzheimer's disease and the trisomy 16 mouse","volume":"11:","author":"Coyle","year":"1988","journal-title":"TINS"},{"key":"10.1006\/exnr.1999.7289_RF12","first-page":"69","article-title":"Down syndrome: Neuropsychology and animal models","volume":"1","author":"Crnic","year":"1999","journal-title":"Prog. Infancy Res."},{"key":"10.1006\/exnr.1999.7289_RF13","first-page":"263","article-title":"Segmental trisomy of murine chromosome 16: A new model system for studying Down syndrome","volume":"360:","author":"Davisson","year":"1990","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1006\/exnr.1999.7289_RF14","first-page":"117","article-title":"Segmental trisomy as a mouse model for Down's syndrome","volume":"348:","author":"Davisson","year":"1993","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1006\/exnr.1999.7289_RF15","series-title":"Mouse Models of Human Genetic Neurological Disease","first-page":"297","article-title":"Mouse models of Down syndrome","author":"Davisson","year":"1999"},{"key":"10.1006\/exnr.1999.7289_RF16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0006-8993(91)91192-4","article-title":"Spatial learning, discrimination learning, paw preference and neocortical ectopias in two autoimmune strains of mice","volume":"562","author":"Denenberg","year":"1991","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1999.7289_RF17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0197-4580(97)00114-0","article-title":"Alzheimer's disease: In vivo detection of differential vulnerability of brain regions","volume":"18","author":"Detoledo-Morrell","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1006\/exnr.1999.7289_RF18","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1023\/A:1011963929012","article-title":"Advances and challenges in the prevention and treatment of Alzheimer's disease","volume":"15","author":"Diaz-Brinton","year":"1998","journal-title":"Pharmaceut. Res."},{"key":"10.1006\/exnr.1999.7289_RF19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0197-0186(96)00071-X","article-title":"Neurotrophins and their receptors in nerve injury and repair","volume":"30","author":"Ebadi","year":"1997","journal-title":"Neurochem. Int."},{"key":"10.1006\/exnr.1999.7289_RF20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1083\/jcb.130.1.149","article-title":"NGF-stimulated tramsport of trkA in the mammalian nervous sytem","volume":"130:","author":"Ehlers","year":"1995","journal-title":"J. Cell Biol."},{"key":"10.1006\/exnr.1999.7289_RF21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0006-8993(94)01414-D","article-title":"Dose\u2013response comparison of recombinant human nerve growth factor and recombinant human basic fibroblast growth factor in the fimbria fornix model of acute cholinergic degeneration","volume":"673","author":"Emmett","year":"1995","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1999.7289_RF22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0304-3940(95)12052-6","article-title":"A behavioral assessment of Ts65Dn mice: A putative Down syndrome model","volume":"199","author":"Escorihuela","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exnr.1999.7289_RF23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0169-328X(96)00193-3","article-title":"Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex","volume":"42","author":"Fahnestock","year":"1996","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1999.7289_RF24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0006-8993(09)90006-3","article-title":"Regional alteration of cholinergic function in central nervous system of trisomy 16 mouse fetuses, an animal model of human trisomy 21 (Down syndrome)","volume":"658","author":"Fiedler","year":"1994","journal-title":"Brain Res."},{"key":"10.1006\/exnr.1999.7289_RF25","first-page":"53","article-title":"Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by NGF","volume":"329:","author":"Fisher","year":"1987","journal-title":"Nature (Lond.)"},{"key":"10.1006\/exnr.1999.7289_RF26","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1523\/JNEUROSCI.11-07-01889.1991","article-title":"NGF improves spatial memory in aged rodents as a function of age","volume":"11:","author":"Fischer","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.1999.7289_RF27","first-page":"206","article-title":"Chance orders of alternating stimuli in visual discrimination experiments","volume":"42","author":"Gellerman","year":"1933","journal-title":"J. Gen. Psychol."},{"key":"10.1006\/exnr.1999.7289_RF28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0165-3806(83)90107-4","article-title":"NGF-mediated increase of choline acetyl-transferase (ChAT) in the neonatal rat forebrain: Evidence for a physiological role of NGF in the brain?","volume":"9","author":"Gnahn","year":"1983","journal-title":"Dev. Brain Res"},{"key":"10.1006\/exnr.1999.7289_RF29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0197-4580(94)90184-8","article-title":"Toward an integrated discovery and development program in Alzheimer's disease: The amyloid hypothesis","volume":"15","author":"Greenberg","year":"1994","journal-title":"Neurobiol. Aging"},{"key":"10.1006\/exnr.1999.7289_RF30","first-page":"309","article-title":"Nerve growth factor is a neurotrophic factor for forebrain cholinergic neurons: Implications for Alzheimer's disease?","volume":"24","author":"Hefti","year":"1987","journal-title":"J. Neural Transm."},{"key":"10.1006\/exnr.1999.7289_RF31","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/00002826-199114001-00008","article-title":"Nerve growth factor and Alzheimer's disease","volume":"14","author":"Hefti","year":"1991","journal-title":"Clin. Neuropharm."},{"key":"10.1006\/exnr.1999.7289_RF32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0304-3940(98)00019-6","article-title":"Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease","volume":"241","author":"Hock","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exnr.1999.7289_RF33","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1212\/WNL.43.12.2668","article-title":"Nerve growth factor reverses neuronal atrophy in a Down syndrome model of age-related neurodegeneration","volume":"43","author":"Holtzman","year":"1993","journal-title":"Neurology"},{"key":"10.1006\/exnr.1999.7289_RF34","series-title":"Etiology and Pathogenesis of Down Syndrome","first-page":"227","article-title":"Preliminary characterization of the central nervous system in partial trisomy 16 mice","author":"Holtzman","year":"1995"},{"key":"10.1006\/exnr.1999.7289_RF35","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1073\/pnas.93.23.13333","article-title":"Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome","volume":"93","author":"Holtzman","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.1999.7289_RF36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3940(98)00641-7","article-title":"Hippocampal volume and neuronal number in Ts65Dn mice: A murine model of Down syndrome","volume":"253","author":"Insausti","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exnr.1999.7289_RF37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0169-328X(94)90159-7","article-title":"NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients","volume":"25","author":"Jette","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1006\/exnr.1999.7289_RF38","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1471-4159.1989.tb01864.x","article-title":"Down syndrome patients begin life with normal levels of brain cholinergic markers","volume":"52","author":"Kish","year":"1989","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.1999.7289_RF39","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/ana.410300613","article-title":"Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates","volume":"30","author":"Koliatsos","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.1999.7289_RF40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1615\/CritRevNeurobiol.v10.i2.40","article-title":"Biological therapies for Alzheimer's disease: Focus on trophic factors","volume":"10","author":"Koliatsos","year":"1996","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1006\/exnr.1999.7289_RF41","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1523\/JNEUROSCI.14-08-04815.1994","article-title":"Human nerve growth factor improves spatial memory in aged but not in young rats","volume":"14:","author":"Markowska","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.1999.7289_RF42","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1523\/JNEUROSCI.16-10-03541.1996","article-title":"Selective effects of nerve growth factor on spatial recent memory is assessed by a delayed nonmatching-to-position task in the water maze","volume":"16","author":"Markowska","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.1999.7289_RF43","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1097\/00001756-199711100-00012","article-title":"Cholinergic, serotonergic, and catecholaminergic neurons are not affected in Ts65Dn mice","volume":"8","author":"Megias","year":"1997","journal-title":"NeuroReport"},{"key":"10.1006\/exnr.1999.7289_RF44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0896-6273(92)90228-6","article-title":"The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth","volume":"9","author":"Milward","year":"1992","journal-title":"Neuron"},{"key":"10.1006\/exnr.1999.7289_RF45","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/00001756-199505090-00028","article-title":"Nerve growth factor in Alzheimer's disease: Defective retrograde transport to nucleus basalis","volume":"6","author":"Mufson","year":"1995","journal-title":"NeuroReport"},{"key":"10.1006\/exnr.1999.7289_RF46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00001756-199612200-00006","article-title":"Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease","volume":"8","author":"Mufson","year":"1996","journal-title":"NeuroReport"},{"key":"10.1006\/exnr.1999.7289_RF47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/exnr.1997.6504","article-title":"Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease","volume":"146","author":"Mufson","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.1999.7289_RF48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/bbrc.1993.1609","article-title":"NGF level is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease","volume":"193","author":"Murase","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/exnr.1999.7289_RF49","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1097\/00001756-199611250-00024","article-title":"Regional specificity of alterations in NGF, BDNF, and NT-3 levels in Alzheimer's disease","volume":"7","author":"Narisawa-Saito","year":"1996","journal-title":"NeuroReport"},{"key":"10.1006\/exnr.1999.7289_RF50","doi-asserted-by":"crossref","first-page":"12644","DOI":"10.1073\/pnas.94.23.12644","article-title":"Cerebral cortical astroglia from the trisomy 16 mouse, a model for down syndrome, produce neuronal cholinergic deficits in cell culture","volume":"94","author":"Nelson","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.1999.7289_RF51","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/bmj.2.6150.1457","article-title":"Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia","volume":"2","author":"Perry","year":"1978","journal-title":"Br. Med. J."},{"key":"10.1006\/exnr.1999.7289_RF52","doi-asserted-by":"crossref","first-page":"8322","DOI":"10.1073\/pnas.88.19.8322","article-title":"Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse","volume":"88","author":"Pittler","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.1999.7289_RF53","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1469-8749.1980.tb04331.x","article-title":"Chromosome 21 of man, 22 of great apes, and 16 of the mouse","volume":"22","author":"Polani","year":"1980","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1006\/exnr.1999.7289_RF54","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ng1095-177","article-title":"A mouse model for Down syndrome exhibits learning and behavioral deficits","volume":"11","author":"Reeves","year":"1995","journal-title":"Nature Genet."},{"key":"10.1006\/exnr.1999.7289_RF55","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1073\/pnas.95.11.6256","article-title":"Ts108Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities","volume":"95","author":"Sago","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.1999.7289_RF56","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0306-4522(96)00273-4","article-title":"Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease","volume":"75","author":"Salehi","year":"1996","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.1999.7289_RF57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3940(94)90253-4","article-title":"Nerve growth factor increases extracellular acetylcholine levels in the parietal cortex and hippocampus of aged rats and restores object recognition","volume":"170:","author":"Scali","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exnr.1999.7289_RF58","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1523\/JNEUROSCI.15-09-06213.1995","article-title":"Nerve growth factor in Alzheimer's disease: Increased levels throughout the brain coupled with declines in nucleus basalis","volume":"15","author":"Scott","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.1999.7289_RF59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0006-8993(84)91338-6","article-title":"Specific retrograde transport of nerve growth factor receptor (NGF) from neocortex to nucleus basalis in the rat","volume":"300","author":"Seiler","year":"1984","journal-title":"Brain Res"},{"key":"10.1006\/exnr.1999.7289_RF60","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/S0028-3908(97)00157-3","article-title":"Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down's syndrome","volume":"36","author":"Siarey","year":"1997","journal-title":"Neuropharmacology"},{"key":"10.1006\/exnr.1999.7289_RF61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ng0597-28","article-title":"Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome","volume":"16","author":"Smith","year":"1997","journal-title":"Nature Genet."},{"key":"10.1006\/exnr.1999.7289_RF62","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/cne.903500407","article-title":"TrkA-immunoreactive profiles in the central nervous system: Colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin","volume":"350","author":"Sobreviela","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"10.1006\/exnr.1999.7289_RF63","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1523\/JNEUROSCI.12-12-04766.1992","article-title":"Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain","volume":"12","author":"Strada","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.1999.7289_RF64","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/379534a0","article-title":"Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice","volume":"379","author":"Sumarsono","year":"1996","journal-title":"Nature"},{"key":"10.1006\/exnr.1999.7289_RF65","first-page":"305","article-title":"Gene therapy in the adult primate brain: Intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration","volume":"3","author":"Tuszynski","year":"1996","journal-title":"Gene Ther."},{"key":"10.1006\/exnr.1999.7289_RF66","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0197-4580(94)90194-5","article-title":"Genes in early onset Alzheimer's disease: Implications for AD research","volume":"15","author":"Van Broeckhoven","year":"1994","journal-title":"Neurobiol. Aging"},{"key":"10.1006\/exnr.1999.7289_RF67","doi-asserted-by":"crossref","first-page":"9231","DOI":"10.1073\/pnas.83.23.9231","article-title":"Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection","volume":"83","author":"Williams","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.1999.7289_RF68","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s001090050250","article-title":"Cholinergic strategies for Alzheimer's disease","volume":"76","author":"Winkler","year":"1998","journal-title":"J. Mol. Med."},{"key":"10.1006\/exnr.1999.7289_RF69","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1172\/JCI119772","article-title":"Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis: Possible mechanism for Alzheimer's disease","volume":"100","author":"Yaar","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1006\/exnr.1999.7289_RF70","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0006-8993(83)91179-4","article-title":"Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome","volume":"280:","author":"Yates","year":"1983","journal-title":"Brain Res."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488699972898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488699972898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T08:00:51Z","timestamp":1576483251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488699972898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["S0014488699972898"],"URL":"https:\/\/doi.org\/10.1006\/exnr.1999.7289","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}